Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lanlan Ji

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
International Journal of Rheumatic Diseases|November 8, 2018
Performance of routine assessment of patient index data 3 (RAPID3) in monitoring disease activity of Chinese rheumatoid arthritis patientsXiaohui Zhang, Anzhi Xie, Yu Wang, et al.
Lupus Science & Medicine|June 30, 2026
Are RAS inhibitors necessary during intensive immunosuppression for lupus nephritis? Real-world evidence from the STAR cohortXiaohui Zhang, Xiuli Zhang, Juan Zhao, et al.
Chinese Medical Journal|February 26, 2026
Validation of the 2023 American College of Rheumatology/European League Against Rheumatism antiphospholipid syndrome classification criteria in a Chinese systemic lupus erythematosus cohortZhuohan Cao, Zhenkai Fu, Xirun Zhu, et al.
Mayo Clinic Proceedings|January 4, 2024
Real-World Clinical Equivalence of Generic and Branded Tofacitinib: A Prospective Longitudinal Cohort Study in Patients With Rheumatoid ArthritisJuan Zhao, Hong Huang, Yu Wang, et al.
Medcomm|March 25, 2024
B cell pathway dual inhibition for systemic lupus erythematosus: a prospective single-arm cohort study of telitaciceptLanlan Ji, Yan Geng, Xiaohui Zhang, et al.
Clinical Rheumatology|October 1, 2021
Determinants and protective associations of the lupus low disease activity state in a prospective Chinese cohortYanjie Hao, Shereen Oon, Lanlan Ji, et al.
Frontiers in Immunology|June 16, 2025
The concordance of swelling/tenderness with ultrasound-detected inflammatory lesions in patients with psoriatic arthritisXiaoying Sun, Yan Geng, Zhibo Song, et al.
Rheumatology and Therapy|June 19, 2023
The Recent Outbreak of COVID-19 in China During the Omicron Variant Predominance: Clinical Features and Outcomes in Patients with Autoimmune Inflammatory Rheumatic DiseasesYan Geng, Yong Fan, Xuerong Deng, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2018
Digitizing omics profiles by divergence from a baselineWikum Dinalankara, Qian Ke, Yiran Xu, et al.
Radiation Oncology (London, England)|January 24, 2018
Comparison of the clinical efficacy between single-agent and dual-agent concurrent chemoradiotherapy in the treatment of unresectable esophageal squamous cell carcinoma: a multicenter retrospective analysisJie Li, Youling Gong, Peng Diao, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
International Journal of Rheumatic Diseases|November 8, 2018
Performance of routine assessment of patient index data 3 (RAPID3) in monitoring disease activity of Chinese rheumatoid arthritis patientsXiaohui Zhang, Anzhi Xie, Yu Wang, et al.
Lupus Science & Medicine|June 30, 2026
Are RAS inhibitors necessary during intensive immunosuppression for lupus nephritis? Real-world evidence from the STAR cohortXiaohui Zhang, Xiuli Zhang, Juan Zhao, et al.
Chinese Medical Journal|February 26, 2026
Validation of the 2023 American College of Rheumatology/European League Against Rheumatism antiphospholipid syndrome classification criteria in a Chinese systemic lupus erythematosus cohortZhuohan Cao, Zhenkai Fu, Xirun Zhu, et al.
Mayo Clinic Proceedings|January 4, 2024
Real-World Clinical Equivalence of Generic and Branded Tofacitinib: A Prospective Longitudinal Cohort Study in Patients With Rheumatoid ArthritisJuan Zhao, Hong Huang, Yu Wang, et al.
Medcomm|March 25, 2024
B cell pathway dual inhibition for systemic lupus erythematosus: a prospective single-arm cohort study of telitaciceptLanlan Ji, Yan Geng, Xiaohui Zhang, et al.
Clinical Rheumatology|October 1, 2021
Determinants and protective associations of the lupus low disease activity state in a prospective Chinese cohortYanjie Hao, Shereen Oon, Lanlan Ji, et al.
Frontiers in Immunology|June 16, 2025
The concordance of swelling/tenderness with ultrasound-detected inflammatory lesions in patients with psoriatic arthritisXiaoying Sun, Yan Geng, Zhibo Song, et al.
Rheumatology and Therapy|June 19, 2023
The Recent Outbreak of COVID-19 in China During the Omicron Variant Predominance: Clinical Features and Outcomes in Patients with Autoimmune Inflammatory Rheumatic DiseasesYan Geng, Yong Fan, Xuerong Deng, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2018
Digitizing omics profiles by divergence from a baselineWikum Dinalankara, Qian Ke, Yiran Xu, et al.
Radiation Oncology (London, England)|January 24, 2018
Comparison of the clinical efficacy between single-agent and dual-agent concurrent chemoradiotherapy in the treatment of unresectable esophageal squamous cell carcinoma: a multicenter retrospective analysisJie Li, Youling Gong, Peng Diao, et al.
Pageof 7